Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sethy PK et al. – Early remission was achieved in group B but the relapse rates during the treatment phase or after stopping therapy were comparable. Both therapies had comparable side–effect profiles, although Group B showed greater steroid–induced adverse events.

Related Articles

Treatment of pemphigus vulgaris and pemphigus foliaceus
Expert Review of Dermatology, 10/13/09    Relevance Score: 66%

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09    Relevance Score: 65%

Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris
Clinical and Experimental Dermatology, 10/08/09    Relevance Score: 65%

Subcorneal Pustular Dermatosis-Type IgA Pemphigus With Autoantibodies to Desmocollins 1, 2, and 3
Archives of Dermatology, 10/22/09    Relevance Score: 44%

Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09    Relevance Score: 43%

Today in Autoimmune/Bullous Dz...keeping you current

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09

The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
Journal of the European Academy of Dermatology and Venereology, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address